Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Aspen Pharmacare Holdings Ltd.

www.aspenpharma.com

Latest From Aspen Pharmacare Holdings Ltd.

Aspen Will Pay UK's NHS £8m In Landmark Deal Following Competition Probe

Aspen has agreed to pay the National Health Service £8m following an investigation by the Competition and Markets Authority.

Compliance Legal Issues

Aspen to Pay UK NHS £8m In Landmark Deal Following Competition Probe

Aspen has agreed to pay the National Health Service £8m following an investigation by the Competition and Markets Authority.

Europe United Kingdom

Aspen Ends Potential Deal For European Business

Aspen has terminated discussions with a potential partner around a deal to help it to optimize its European pharmaceuticals business.

Deals Strategy

Strides Exits Australia To ‘Double-Down’ On US Market

Strides founder Arun Kumar says he’s succeeded in putting the company back on the road to health after it shocked financial markets by swinging to a quarterly loss last year. But as part of the recovery plan, the company is selling its key Australia generic business to “double-down” on the US market.
Commercial Strategy
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register